Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Mechanisms of vaccine adjuvanticity at mucosal surfaces.
D. L. Foss
, Michael P Murtaugh
Veterinary and Biomedical Sciences
Research output
:
Contribution to journal
›
Review article
›
peer-review
30
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Mechanisms of vaccine adjuvanticity at mucosal surfaces.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Mucosal Surfaces
100%
Vaccine Adjuvant
100%
Oral Vaccine
100%
Adjuvanticity
100%
Vaccination
50%
Vaccine Candidate
50%
Molecular Mechanism
50%
Rational Development
50%
Immunization
50%
Intestinal Immunity
50%
Protective Immunity
50%
Gut mucosa
50%
Infection Prevention
50%
Mucosal Adjuvant
50%
Inflammatory Response
50%
Vaccine Delivery
50%
Intestine
50%
Immunogenic
50%
Cholera Toxin
50%
General Mechanism
50%
Costimulatory Molecules
50%
Gut-associated Lymphoid Tissue
50%
Medicine and Dentistry
Mucosal Surface
100%
Adjuvant
100%
Gut
66%
Oral Vaccine
66%
Vaccine Adjuvant
66%
Pathogen
33%
Infection
33%
Serositis
33%
Cytokine
33%
Mucosa
33%
Gut-Associated Lymphoid Tissue
33%
Cholera Toxin
33%
Antigen
33%
Diseases
33%
Immunology and Microbiology
Adjuvant
100%
Vaccine Adjuvant
66%
Infectious Disease
33%
Antigen
33%
Gut-Associated Lymphoid Tissue
33%
Inflammation Response
33%
Infectious Agent
33%
Mucosa
33%
Intestine
33%
Cytokine
33%
Cholera Toxin
33%
Infection
33%